Rossari Biotech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 November 2024 .Powered by Capital Market - Live News

Net profit of Rossari Biotech rose 7.22% to Rs 35.33 crore in the quarter ended September 2024 as against Rs 32.95 crore during the previous quarter ended September 2023. Sales rose 3.08% to Rs 498.35 crore in the quarter ended September 2024 as against Rs 483.47 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales498.35483.47 3 OPM %13.2313.15 - PBDT63.2759.92 6 PBT48.1144.81 7 NP35.3332.95 7 Powered by Capital Market - Live News

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live News

Rossari Biotech announced that the 15th Annual General Meeting (AGM) of the company will be held on 23 August 2024.Powered by Capital Market - Live News

Net profit of Rossari Biotech rose 19.44% to Rs 34.90 crore in the quarter ended June 2024 as against Rs 29.22 crore during the previous quarter ended June 2023. Sales rose 19.25% to Rs 489.65 crore in the quarter ended June 2024 as against Rs 410.61 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales489.65410.61 19 OPM %13.2514.05 - PBDT62.3653.57 16 PBT46.9939.46 19 NP34.9029.22 19 Powered by Capital Market - Live News